Have the number of pulmonary embolism cases increased during the COVID-19 pandemic?

dc.authorid0000-0002-2450-6378en_US
dc.authorid0000-0001-5842-7849en_US
dc.authorid0000-0002-8240-4775en_US
dc.authorid0000-0002-6144-3433en_US
dc.authorid0000-0002-4914-2080en_US
dc.contributor.authorAfşin, Emine
dc.contributor.authorÖzsarı, Emine
dc.contributor.authorKonuk, Suat
dc.contributor.authorKocadağ, Derya
dc.contributor.authorBacaksız, Emre
dc.date.accessioned2023-07-27T07:51:39Z
dc.date.available2023-07-27T07:51:39Z
dc.date.issued2022en_US
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractBackground. Coagulation disorders, endothelial dysfunction, immobility and dehydration contribute to deep vein throm-bosis (DVT) and pulmonary embolism (PE) in COVID-19 patients. While the prevalence of PE accompanying COVID-19 is high, the number of studies on its long-term effects is limited in literature. Objectives. We expanded this process and aimed to evaluate a one-year period before and during the pandemic. We sought an answer to the question: "Is there a change in the frequency and clinical course of PE?" Material and methods. Retrospectively, all patients admitted to our pulmonology clinic diagnosed with PE between October 2018-2019 (pre-pandemic) and April 2020-2021 (pandemic period) were included in the study. PE patients hospitalized due to COVID-19 infection were not included in the study. Results. The prevalence of PE cases increased by 43% in the first year of the pandemic, and there was no significant difference in terms of symptoms, localisation and extent of thrombus in the pulmonary artery, DVT frequency, systolic pulmonary artery pressure (PABs) values, right heart load, frequency of thrombolytic therapy and mortality rates. A significant decrease was observed in predisposing factors of pulmonary embolism only in the postoperative period (7 patients (77.8%) before the pandemic; 2 patients (22.2%) during the pandemic; p = 0.029). Conclusions. PE cases are encountered more frequently during the pandemic process, and no significant change was seen in patient's clinical findings and mortality.en_US
dc.identifier.citationAfşin, E., Özsari, E., Konuk, S., Kocadağ, D., & Bacaksiz, E. (2022). Have the number of pulmonary embolism cases increased during the COVID-19 pandemic?. Family Medicine & Primary Care Review, 24(2).en_US
dc.identifier.doi10.5114/fmpcr.2022.115868
dc.identifier.endpage115en_US
dc.identifier.issn1734-3402
dc.identifier.issn2449-8580
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85136806763en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage111en_US
dc.identifier.urihttp://dx.doi.org/10.5114/fmpcr.2022.115868
dc.identifier.urihttps://hdl.handle.net/20.500.12491/11377
dc.identifier.volume24en_US
dc.identifier.wosWOS:000835179500002en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorAfşin, Emine
dc.institutionauthorÖzsarı, Emine
dc.institutionauthorKonuk, Suat
dc.institutionauthorBacaksız, Emre
dc.language.isoenen_US
dc.publisherTermedia Publishing House Ltden_US
dc.relation.ispartofFamily Medicine and Primary Care Reviewen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPulmonary Embolismen_US
dc.subjectCOVID-19en_US
dc.subjectPrognosisen_US
dc.subjectLymphocyte Ratioen_US
dc.subjectPrognostic Valueen_US
dc.subjectNeutrophilen_US
dc.titleHave the number of pulmonary embolism cases increased during the COVID-19 pandemic?en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
emine-afsin.pdf
Boyut:
507.24 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/Full text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: